Medicine

Сообщения

MEK Inhibitors Show Promising Potential in Pseudo COVID-19 Study

января 28, 2021

A promising new treatment option for the coronavirus was studied using a COVID-19 pseudovirus approach to observe its immune response to MEK inhibitors. 3D Illustration of COVID-19 3D Illustration of Coronavirus COVID-19 As researchers around the world are in the midst of searching for treatment options capable of combatting the COVID-19 virus, a single solution will not be effective for everyone—in both a logistical and biological sense. To produce different treatment options for populations of varying age and immune system health, numerous avenues are currently being explored. One potential treatment, studied by a coalition of researchers from Brown University, the Fox Chase Cancer Center, and Verastem Oncology, used a COVID-19 pseudovirus approach to demonstrate immune response to MEK inhibitors in a level 2 biosafe environment. The paper detailing this study has been published at Oncotarget.com. oncotarget breakthrough “For the current study, we have developed a pseudotyped SAR

Далее...

clinics in us

января 27, 2021

When general population discuss today’s medicine, accuracy plays one of the most significant roles and people’s lives are literally dependent on it. Hence, any researches related to medicine are necessary to meet the highest standards. The problem today is that any outcomes of researches can be published online and used as a reference without being precisely checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this challenge and tried to develop an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The main principle of this journal is based on Altmetric scores that are used as a quality measure. That helps both readers and authors to validate publications with Altmetric Article Reports that generate “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a full publications list with corresponding scores above 100 as well a

Далее...

Trending with Impact: Basal Cell Bladder Cancer and MEK Inhibitors

января 26, 2021

For patients with basal cell bladder cancer, researchers in this study identify MEK inhibitors as a viable therapeutic option. Onco Youtube 3d Illustration – Bladder cancer cell The Trending with Impact series highlights publications attracting higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news and articles about the latest trending publications here and at Oncotarget.com. — Facebook Oncotarget “Basal bladder cancer is frequently clinically aggressive and has the worst overall prognosis [3], and thus, additional therapeutic options for these tumors would be highly clinically relevant.” Oncotarget’s In this paper published by Oncotarget, researchers from the University of Michigan conducted a study emphasizing the importance of 3D culture screenings versus 2D, and the use of MEK inhibitors to target basal cell bladder cancer. This paper concludes that basal cell bladder cancer cel

Далее...

clinics in us

января 26, 2021

When general population mention today’s medicine, accuracy plays one of the most crucial roles and human lives are directly dependent on it. Likewise, any researches pertaining to medicine are required to meet the top standards. The issue nowadays is that any outcomes of researches can be published online and used as a reference without being thoroughly checked and validated. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this problem and attempted to develop an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been established back in 2010. The main principle of this journal is related to Altmetric scores that are used as a quality indicator. That assists both readers and authors to quality-check publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication. ” Oncotarget website has a complete publications list with respective scores higher t

Далее...

clinics in us

января 21, 2021

When public refer to today’s medicine, precision plays one of the most significant roles and human lives are directly dependent on it. Likewise, any researches pertaining to medicine are necessary to meet the highest standards. The issue nowadays is that any recommendations of researches can be published online and used as a reference without being thoroughly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this problem and decided to generate an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The major principle of this journal is related to Altmetric scores that are used as a quality measure. That helps both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication. ” Oncotarget website provides a complete publications list with corresponding scores above 100 as

Далее...

Trending with Impact: Nimotuzumab Improves Non-HPV Oropharynx Cancers

января 21, 2021

Researchers perform a phase three subgroup analysis study demonstrating positive results in patients with HPV-negative oropharyngeal cancers due to the addition of weekly nimotuzumab doses while receiving cisplatin and radiation treatment. Hospital This image depicts the nasopharynx, pharynx, and the oropharynx. This image illustrates the nasopharynx, pharynx, and the oropharynx. The Trending with Impact series highlights Oncotarget publications attracting higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news and articles about the latest trending publications here, and at Oncotarget.com. Oncotarget’s Listen to an audio version of this article Each year, oral cancer accounts for around 53,000 new patient diagnoses in the United States. However, the highest number of cases of oral cancer in the world are found in India (primarily due to tobacco use)—and researchers say this n

Далее...